VIOMICS
Viomics provides extensive sequencing capabilities and expertise in identifying unique biomarkers that indicate the presence of cancer in solid tissue and blood.
Similar Organizations
colon cancer fund
Colon Cancer Fund is a non profit organization providing prevention, funding for research and patient support services for colon cancer.
Cytocell
Cytocell is a provider of innovative DNA screening solutions for accurate detection of human genetic diseases in cytogenetics and cancer.
EVEXyS
EVEXyS develops novel test systems based protein biomarker patterns & enzyme activities
Prolivida
Prolivida biomedical provides improving reproductive health by developing new molecular tests on the gene expression of sperm.
Umut Biotechnology
Population and ethnicity specific genetic risk assessment test using DNA biomarkers for breast cancer.
Official Site Inspections
http://www.viomics.com
- Host name: ec2-54-215-31-113.us-west-1.compute.amazonaws.com
- IP address: 54.215.31.113
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Viomics"
Viomics - Crunchbase Company Profile & Funding
Viomics provides extensive sequencing capabilities and expertise in identifying unique biomarkers that indicate the presence of cancer in solid tissue and blood.See details»
Viomics Company Profile 2024: Valuation, Investors, …
Information on acquisition, funding, cap tables, investors, and executives for Viomics. Use the PitchBook Platform to explore the full profile.See details»
Viomics - VentureRadar
Viomics is a molecular diagnostics company that uses innovative scientific, engineering, and business strategies to discover, develop and deliver paradigm changing cancer detection …See details»
Patient Services - International Genomics Consortium
Mar 3, 2020 · Additionally, IGC supported the development of Viomics, an organization focused on developing a blood-based assay for the early detection of lung and other cancer. Paradigm …See details»
Viomics, Inc. Company Profile | Phoenix, AZ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Viomics, Inc. of Phoenix, AZ. Get the latest business insights from Dun & Bradstreet.See details»
Viomics - Products, Competitors, Financials, Employees, …
Viomics is a molecular diagnostics company that uses scientific, engineering and business strategies to discover, develop and deliver paradigm-changing cancer detection applications to …See details»
Exact Sciences Corporation - Exact Sciences Extends Leadership In ...
Mar 3, 2020 · (NASDAQ: EXAS) – Exact Sciences Corp. today announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies …See details»
Exact Sciences acquires Viomics - 2020-03-03 - Crunchbase
Mar 3, 2020 · Viomics Viomics provides extensive sequencing capabilities and expertise in identifying unique biomarkers that indicate the presence of cancer. Acquiring Organization: …See details»
Viomics - Crunchbase
Viomics provides extensive sequencing capabilities and expertise in identifying unique biomarkers that indicate the presence of cancer.See details»
Phoenix Based Paradigm And Viomics Acquired by Exact Sciences
On March 3, 2020, Exact Sciences Corp. (NASDAQ: EXAS) announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies …See details»
ASU Startup Viomics Wins $250,000 in Funding from …
Jun 22, 2013 · Arizona State University startup company Viomics has received $250,000 from the Arizona Commerce Authority (ACA) to continue developing innovative cancer detection technologies that save lives by enabling the early …See details»
Viomics’s Competitors, Revenue, Number of Employees, Funding …
Viomics’s Profile, Revenue and Employees. Viomics is a biotechnology company that provides genetic and molecular testing solutions for the treatment of cancer. Viomics’s primary …See details»
Exact Sciences Extends Leadership In Advanced Cancer …
Mar 3, 2020 · Together, Paradigm and Viomics provide a differentiated late-stage therapy selection test and deep competencies in sequencing and biomarker discovery, extending …See details»
Viomics | VentureRadar
Viomics is a molecular diagnostics company that uses innovative scientific, engineering, and business strategies to discover, develop and deliver paradigm changing cancer detection …See details»
Exact Sciences Corporation - Exact Sciences Completes …
Nov 8, 2019 · With a best-in-class R&D, clinical, and commercial organization and a global infrastructure, we are well positioned to increase adoption of our existing tests and accelerate …See details»
ASU startup Viomics wins funding from Arizona Commerce Authority
Jun 24, 2013 · Arizona State University startup company Viomics has received $250,000 from the Arizona Commerce Authority (ACA) to continue developing innovative cancer detection …See details»
Exact Sciences Acquires Paradigm and Viomics | Knobbe Martens
Mar 23, 2020 · Viomics provides extensive sequencing capabilities and expertise in identifying unique biomarkers that can indicate presence of cancer in solid tissue or blood. Exact …See details»
Exact Sciences closes takeovers of 2 cancer testing businesses
Mar 4, 2020 · Exact Sciences has closed the acquisitions of Paradigm Diagnostics and Viomics, adding to its oncology testing capabilities as it looks to expand beyond its flagship Cologuard …See details»
Exact Sciences Continues M&A Strategy to Reach Further Into
May 5, 2021 · NEW YORK – Exact Sciences' quest to cover every inch of the cancer diagnostics market isn't over yet. On Tuesday, the company announced it had acquired PFS Genomics, a …See details»
Exact Sciences Boosting Position in Cancer Dx Market Through M&A
Feb 12, 2020 · The company announced during its Q4 earnings call that it had acquired Paradigm Diagnostics and Viomics to fill out its expertise in cancer diagnostics.See details»